Skip to main content
OpenTrials

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,462 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

Global Syphilis Sequencing

NCT03709862

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +9 more
Locations
  • University Hospitals Birmingham Birmingham, United Kingdom
  • Brighton and Sussex NHS Trust Brighton, United Kingdom
  • Leeds University Teaching Hospital Leeds, United Kingdom
  • Mortimer Market Centre London, United Kingdom
View Trial Details
Completed

Immunising Mums Against Pertussis 3

NCT03578120

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Bordetella Infections, +7 more
Locations
  • Gloucestershire NHS Trust Gloucester, United Kingdom
  • St George's, University of London London, United Kingdom
  • Oxford Vaccine Group Oxford, United Kingdom
View Trial Details
Completed

Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children

NCT03476135

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • Sanofi Pasteur Investigational Site 2460005 Espoo, Finland
  • Sanofi Pasteur Investigational Site 2460006 Helsinki, Finland
  • Sanofi Pasteur Investigational Site 2460002 Helsinki, Finland
  • Sanofi Pasteur Investigational Site 2460007 Jarvenpaa, Finland
View Trial Details
Completed

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

NCT02428491

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations
  • Preventive Medicine Centre of Thai Binh Province Thái Bình, Vietnam
View Trial Details
Completed

Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

NCT02842853

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Birmingham, Alabama, United States
  • Dothan, Alabama, United States
  • Mobile, Alabama, United States
  • Glendale, Arizona, United States
View all 89 locations
View Trial Details
Completed

Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine

NCT02752906

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Investigational Site Number 016 Birmingham, Alabama, United States
  • Investigational Site Number 032 Dothan, Alabama, United States
  • Investigational Site Number 026 Mesa, Arizona, United States
  • Investigational Site Number 022 Jonesboro, Arkansas, United States
View all 30 locations
View Trial Details
Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older

NCT02842866

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Chandler, Arizona, United States
  • Anaheim, California, United States
  • San Diego, California, United States
  • Waterbury, Connecticut, United States
View all 36 locations
View Trial Details

Related conditions